Beranda › PPOK › Michigan › Dearborn
Uji klinis PPOK di Dearborn, MI
4 studi untuk PPOK mencari peserta di lokasi sekitar Dearborn (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Menerima pesertaFase 3
- Vitalis Clinical Research Center- Site Number : 8400040, Allen Park · 5 mi jauhnya
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Menerima pesertaFase 2/3
- Revival Research Institute, LLC, Dearborn
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Menerima pesertaFase 3
- GSK Investigational Site, Dearborn
- GSK Investigational Site, Allen Park · 5 mi jauhnya
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Menerima pesertaFase 3
- GSK Investigational Site, Allen Park · 5 mi jauhnya
Uji klinis PPOK di kota lain
- Philadelphia, PA23 studi
- Miami, FL18 studi
- Birmingham, AL17 studi
- Boston, MA17 studi
- Orlando, FL15 studi
- Houston, TX15 studi
- Baltimore, MD14 studi
- Chicago, IL14 studi
- Pittsburgh, PA12 studi
- Dallas, TX12 studi
- New York City, NY11 studi
- Ann Arbor, MI10 studi
Studi lain di Dearborn
- Kanker Prostat6 studi
- Kanker Paru6 studi
- Kanker Paru Non-Sel Kecil6 studi
- Kanker Payudara6 studi
- Kanker Ginjal (Karsinoma Sel Renal)4 studi
- Kanker Kandung Kemih4 studi
- Kanker Kolorektal4 studi
- Diabetes Tipe 23 studi
- Kanker Pankreas3 studi
- Kanker Ovarium3 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.